imatinib mesylate (NorthStar RxLLC)
Welcome to the PulseAid listing for the imatinib mesylate drug offered from NorthStar RxLLC. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NorthStar RxLLC |
NON-PROPRIETARY NAME: | imatinib mesylate |
SUBSTANCE NAME: | IMATINIB MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-11-01 |
END MARKETING DATE: | 0000-00-00 |
imatinib mesylate HUMAN PRESCRIPTION DRUG Details:
Item Description | imatinib mesylate from NorthStar RxLLC |
LABELER NAME: | NorthStar RxLLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2017-11-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16714-704_f27f254e-8d44-4442-84fb-f0745a5342fb |
PRODUCT NDC: | 16714-704 |
APPLICATION NUMBER: | ANDA078340 |
Other IMATINIB MESYLATE Pharmaceutical Manufacturers / Labelers: